Andere Sprachen AegirBio AB

Aktien

A2P7ZC

SE0014401121

AEGIR

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 18:00:00 01.07.2024			% 5 Tage	% 1. Jan.
0,425 ^SEK	-11,09 %		-3,95 %	-63,68 %

04.06.	Schwedisches Unternehmen AegirBio wird in MagnOral umbenannt	MT
17.05.	AegirBio AB (publ) meldet Ergebniszahlen für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

AegirBio AB has received payment of Tranche 2 of SEK 5.00 million from Atlas Special Opportunities, LLC	27.06.
AegirBio receives second milestone payment under RadX NIH	11.06.
Sweden's AegirBio to Change Name to MagnOral	04.06.
AegirBio announces strategic name change to MagnOral AB	04.06.
AegirBio AB carries out previously announced directed share issue of 5,175,374 shares corresponding to approximately SEK 2.54 million to Atlas Special Opportunities and calls for payment of Tranche 2	30.05.
AegirBio's CEO Marco Witteveen to Attend SalivaDirect's 3rd Annual Conference in Washington, DC, June 5-7, 2024	29.05.
AEGIRBIO AB SUCCESSFULLY COMPLETES AN ADDITIONAL MILESTONE OF RADx® TECH PROGRAM	21.05.
AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024	17.05.
AEGIRBIO study published in Multiple Sclerosis and Related Disorders journal	16.05.
AegirBio AB Announces the Findings of Recent Study Published in the Multiple Sclerosis and Related Disorders Journal	16.05.
AegirBio AB calls for payment of Tranche 1 of SEK 7.50 million and intends to carry out a directed set-off issue of 5,175,374 shares to Atlas Special Opportunities, LLC	13.05.
AEGIRBIO Receives Milestone Payment under RadX NIH	08.05.
AEGIRBIO AB ADVANCES FURTHER WITH "ACCESSIBILITY" MILESTONE COMPLETION IN RADx® TECH PROGRAM	30.04.
AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract	19.04.
AegirBio AB's subsidiary initiates arbitration against Salofa Oy	18.04.
AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas	09.04.
AegirBio Chairman to Resign	09.04.
AegirBio's chairman has announced his intention to leave the board of directors	09.04.
AegirBio AB Announces Intention of Anders Ingvarsson to Resign as Board Member and Chairman	09.04.
AegirBio enters into a conditional agreement on a MSEK 45 loan facility with Atlas Special Opportunities and an agreement to amend the outstanding convertible bonds, subject to EGM approval	09.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AegirBio AB

Aktien

A2P7ZC

SE0014401121

AEGIR

Andere Sprachen

Filter